Cancer BiologyNAR CancerPeer-reviewed
Efficient gene disruption with CRISPR-Cas3 in human T cells
Tomoaki Fujii, Yukimi Sakoda, Kazuto Yoshimi…·Tomoji Mashimo
This study demonstrates that CRISPR-Cas3 can efficiently and safely disrupt genes in human T cells, reducing off-target effects and alloreactivity while maintaining cytotoxicity.
1 citation